234 related articles for article (PubMed ID: 24343214)
1. Disease burden and treatment adherence in psoriasis patients.
Feldman SR
Cutis; 2013 Nov; 92(5):258-63. PubMed ID: 24343214
[TBL] [Abstract][Full Text] [Related]
2. [Topical treatment adherence for psoriasis].
Halioua B
Rev Prat; 2012 Feb; 62(2):156-9. PubMed ID: 22408849
[No Abstract] [Full Text] [Related]
3. Physician perception of patient adherence compared to patient adherence of osteoporosis medications from pharmacy claims.
Copher R; Buzinec P; Zarotsky V; Kazis L; Iqbal SU; Macarios D
Curr Med Res Opin; 2010 Apr; 26(4):777-85. PubMed ID: 20095797
[TBL] [Abstract][Full Text] [Related]
4. Patients' educational needs about topical treatments for psoriasis.
Martin SL; McGoey ST; Bebo BF; Feldman SR
J Am Acad Dermatol; 2013 Jun; 68(6):e163-8. PubMed ID: 22682885
[TBL] [Abstract][Full Text] [Related]
5. Determining the relative importance of patient motivations for nonadherence to topical corticosteroid therapy in psoriasis.
Brown KK; Rehmus WE; Kimball AB
J Am Acad Dermatol; 2006 Oct; 55(4):607-13. PubMed ID: 17010739
[TBL] [Abstract][Full Text] [Related]
6. Educational and motivational support service: a pilot study for mobile-phone-based interventions in patients with psoriasis.
Balato N; Megna M; Di Costanzo L; Balato A; Ayala F
Br J Dermatol; 2013 Jan; 168(1):201-5. PubMed ID: 23240729
[TBL] [Abstract][Full Text] [Related]
7. Approaching psoriasis differently: patient-physician relationships, patient education and choosing the right topical vehicle.
Feldman SR
J Drugs Dermatol; 2010 Aug; 9(8):908-11. PubMed ID: 20684140
[TBL] [Abstract][Full Text] [Related]
8. A prospective study of patient adherence to topical treatments: 95% of patients underdose.
Storm A; Benfeldt E; Andersen SE; Serup J
J Am Acad Dermatol; 2008 Dec; 59(6):975-80. PubMed ID: 18817998
[TBL] [Abstract][Full Text] [Related]
9. Psoriasis: improving adherence to topical therapy.
Feldman SR; Horn EJ; Balkrishnan R; Basra MK; Finlay AY; McCoy D; Menter A; van de Kerkhof PC;
J Am Acad Dermatol; 2008 Dec; 59(6):1009-16. PubMed ID: 18835062
[TBL] [Abstract][Full Text] [Related]
10. Non-adherence and measures to improve adherence in the topical treatment of psoriasis.
Zschocke I; Mrowietz U; Karakasili E; Reich K
J Eur Acad Dermatol Venereol; 2014 May; 28 Suppl 2():4-9. PubMed ID: 24684738
[TBL] [Abstract][Full Text] [Related]
11. Moderate to severe psoriasis: from topical to biological treatment.
Gardinal I; Ammoury A; Paul C
J Eur Acad Dermatol Venereol; 2009 Nov; 23(11):1324-6. PubMed ID: 19470061
[TBL] [Abstract][Full Text] [Related]
12. Adherence and patient satisfaction with topical treatment in psoriasis, and the use, and organoleptic properties of such treatments: a Delphi study with an expert panel and members of the Psoriasis Group of the Spanish Academy of Dermatology and Venereology.
Puig L; Carrascosa JM; Belinchón I; Fernández-Redondo V; Carretero G; Ruiz-Carrascosa JC; Careaga JM; de la Cueva P; Gárate MT; Ribera M; ;
Actas Dermosifiliogr; 2013; 104(6):488-96. PubMed ID: 23395400
[TBL] [Abstract][Full Text] [Related]
13. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey.
Krueger G; Koo J; Lebwohl M; Menter A; Stern RS; Rolstad T
Arch Dermatol; 2001 Mar; 137(3):280-4. PubMed ID: 11255325
[TBL] [Abstract][Full Text] [Related]
14. Quality of life and cost of illness in patients with psoriasis in Malaysia: a multicenter study.
Tang MM; Chang CC; Chan LC; Heng A
Int J Dermatol; 2013 Mar; 52(3):314-22. PubMed ID: 23414155
[TBL] [Abstract][Full Text] [Related]
15. Increasing adherence to topical therapy in psoriasis through use of solution medication.
Hill D; Farhangian ME; Feldman SR
Dermatol Online J; 2016 May; 22(5):. PubMed ID: 27617530
[TBL] [Abstract][Full Text] [Related]
16. Perception of disease and doctor-patient relationship experienced by patients with psoriasis: a questionnaire-based study.
Linder D; Dall'olio E; Gisondi P; Berardesca E; Gennaro ED; Pennella AR; Giannetti A; Peserico A; Girolomoni G
Am J Clin Dermatol; 2009; 10(5):325-30. PubMed ID: 19658445
[TBL] [Abstract][Full Text] [Related]
17. Psoriasis uncovered--measuring burden of disease impact in a survey of Australians with psoriasis.
Baker CS; Foley PA; Braue A
Australas J Dermatol; 2013 Feb; 54 Suppl 1():1-6. PubMed ID: 23379483
[TBL] [Abstract][Full Text] [Related]
18. Psoriasis treatments by payment type in the US outpatient office setting.
Mireku K; Huang KE; Narahari S; Davis SA; Feldman SR
J Drugs Dermatol; 2013 Oct; 12(10):1095-7. PubMed ID: 24085043
[TBL] [Abstract][Full Text] [Related]
19. Even well-controlled psoriasis patients have unmet treatment needs regardless of disease severity.
Vaidya TS; Anderson KL; Feldman SR
Dermatol Online J; 2015 Sep; 21(9):. PubMed ID: 26437293
[TBL] [Abstract][Full Text] [Related]
20. Nonadherence to psoriasis medication as an outcome of limited coping resources and conflicting goals: findings from a qualitative interview study with people with psoriasis.
Thorneloe RJ; Bundy C; Griffiths CE; Ashcroft DM; Cordingley L
Br J Dermatol; 2017 Mar; 176(3):667-676. PubMed ID: 27664406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
